Rheumatoid arthritis in Saudi Arabia
- PMID: 25491208
- PMCID: PMC4362178
Rheumatoid arthritis in Saudi Arabia
Abstract
The status of rheumatoid arthritis (RA) in Saudi Arabia (SA) was examined from various perspectives based on a systematic literature review and the authors' personal experiences. In this regard, database and journal search were conducted to identify studies on RA in SA, yielding a total of 43 articles. Although efforts have been made to promote RA research in SA, current studies mostly represent only a few centers and may not accurately portray the national status of RA care. Notably, biological therapies were introduced early for almost all practicing rheumatologists in SA (government and private). However, no national guidelines regarding the management of RA have been developed based on local needs and regulations. Also, while efforts were made to establish RA data registries, they have not been successful. Taken together, this analysis can contribute to the planning of future guidelines and directives for RA care in SA.
Comment in
-
Rheumatoid arthritis in the Kingdom of Saudi Arabia.Saudi Med J. 2015 May;36(5):638. doi: 10.15537/smj.2015.5.11639. Saudi Med J. 2015. PMID: 25935189 Free PMC article. No abstract available.
-
Rheumatoid arthritis in the Kingdom of Saudi Arabia. Reply from the Author.Saudi Med J. 2015 May;36(5):638-9. Saudi Med J. 2015. PMID: 26131457 No abstract available.
Similar articles
-
The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. doi: 10.3310/hta8180. Health Technol Assess. 2004. PMID: 15130461
-
Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.Pharmacoeconomics. 2014 Feb;32(2):109-34. doi: 10.1007/s40273-013-0120-z. Pharmacoeconomics. 2014. PMID: 24338344
-
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420. Health Technol Assess. 2006. PMID: 17049139
-
The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.Health Technol Assess. 2004 Mar;8(11):iii, 1-91. doi: 10.3310/hta8110. Health Technol Assess. 2004. PMID: 14982655
-
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.Health Technol Assess. 2016 Apr;20(35):1-610. doi: 10.3310/hta20350. Health Technol Assess. 2016. PMID: 27140438 Free PMC article.
Cited by
-
Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South-Western Saudi Arabia: A Retrospective Study.Open Access Rheumatol. 2021 Aug 14;13:239-246. doi: 10.2147/OARRR.S322833. eCollection 2021. Open Access Rheumatol. 2021. PMID: 34429668 Free PMC article.
-
Saudi cultural adaptation of the "compliance questionnaire of Rheumatology" for Rheumatoid arthritis patients on disease modifying anti-rheumatic drugs (DMARDs).Saudi Pharm J. 2021 May;29(5):377-383. doi: 10.1016/j.jsps.2021.03.007. Epub 2021 Mar 24. Saudi Pharm J. 2021. PMID: 34135664 Free PMC article.
-
Retinoic Acid-Platinum (II) Complex [RT-Pt(II)] Protects Against Rheumatoid Arthritis in Mice via MEK/Nuclear Factor kappa B (NF-κB) Pathway Downregulation.Med Sci Monit. 2020 Aug 3;26:e924787. doi: 10.12659/MSM.924787. Med Sci Monit. 2020. PMID: 32741960 Free PMC article.
-
Preferred Mode of Therapy Among Patients in Rheumatoid Arthritis Saudi Database: A Cross-Sectional Study.Cureus. 2023 Jun 27;15(6):e41014. doi: 10.7759/cureus.41014. eCollection 2023 Jun. Cureus. 2023. PMID: 37519580 Free PMC article.
-
Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.PLoS One. 2018 Mar 20;13(3):e0193451. doi: 10.1371/journal.pone.0193451. eCollection 2018. PLoS One. 2018. PMID: 29558494 Free PMC article.
References
-
- Mjaavatten MD, Bykerk VP. Early rheumatoid arthritis: the performance of the 2010 ACR/EULAR criteria for diagnosing RA. Best Pract Res Clin Rheumatol. 2013;27:451–466. - PubMed
-
- Sanmartí R, Ruiz-Esquide V, Hernández MV. Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches. Curr Top Med Chem. 2013;13:698–704. - PubMed
-
- Grassi W, Davies A, Boumendil O. Recent Trends and Technology Advances in Rheumatoid Arthritis Clinical and Ultrasonography and Power Doppler Imaging. European Musculoskeletal Review. 2011;6:148–152.
-
- Atwa MA, Balata MG, Hussein AM, Abdelrahman NI, Elminshawy HH. Serum 25-hydroxyvitamin D concentration in patients with psoriasis and rheumatoid arthritis and its association with disease activity and serum tumor necrosis factor-alpha. Saudi Med J. 2013;34:806–813. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical